Accuray swings to FY27 first-quarter net income of $10.1 million; revenue falls 8% to $86.5 million

By Public Technologies21:14 (UTC), 4 November 2026 Updated

Accuray swung to net income of $10.1 million in its FY27 first quarter from a year-earlier loss.
Results included a $59.6 million non-cash gain on extinguishment of debt and a $35.4 million non-cash goodwill impairment charge.
Revenue fell 8% to $86.5 million, while gross product orders dropped 50% to $19.8 million year-over-year.
A definitive agreement with RaySearch aims to accelerate online adaptive radiation therapy, while collaboration with Samsung NeuroLogica advanced CyberKnife volumetric imaging.
Management continues to withhold formal FY27 revenue or adjusted EBITDA guidance, prioritizing stronger product revenue and order performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accuray Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-034929), on November 04, 2026, and is solely responsible for the information contained therein.